Search results
MI and Non-obstructive Coronary Arteries
Added:
1 year ago
Review Article
Added:
1 year ago
LINC 2025 - Outcomes from the GRIFFIN study suggest post-procedural functional flow reserve (FFR) could be a useful predictor of restenosis after drug-coated balloon (DCB) angioplasty for superficial femoral artery (SFA) lesions. Restenosis patients showed significantly lower FFR values than non-restenosis patients, and the study resulted in a good FFR cut-off value of restenosis after DCB…
View more
Added:
1 year ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further…
View more
Added:
1 year ago
ADA 24 - In this succinct video, we are joined by Dr Vlado Perkovic (UNSW Sydney, Kensington, AU) to discuss a trial investigating the use of semaglutide in patients with type 2 diabetes and chronic kidney disease (NCT03819153).The FLOW trial enrolled 3533 participants with type 2 diabetes and chronic kidney disease, who were then randomized to recieve either semaglutide or placebo. The median…
View more
Added:
1 year ago
AHA Conference 2024 — Semaglutide shows increased benefits in CKD patients based on their cardiovascular status and risk profile.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Katherine Tuttle (University of Washington, US) to discuss the effects of semaglutide in patients with chronic kidney disease (CKD).The FLOW trial (NCT03819153) is designed to assess the effect of…
View more
Anomalous Coronary Artery Origin
Added:
1 year ago
Case Report
Added:
7 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients…
View more
Assessing Coronary Angiography Interpretation Education
Added:
1 year ago
Original Research
Start date:
Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination…
View more
Added:
3 weeks ago
ACC.26 – Dr Ajay Kirtane (NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, US) discusses the ALL-RISE trial (NCT05893498), a large-scale, global, prospective, randomised, multicentre study comparing FFRangio-based, angiography-derived coronary physiology with conventional pressure wire-guided FFR/NHPR to direct PCI in patients with coronary artery disease.This pivotal non…
View more